ANGO vs RTX · rev $292.5M vs P/E 36, rev $88.60B
AngioDynamics Inc (ANGO) versus RTX Corporation (RTX) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported RTX revenue for 2025-12-31 was $88.60B. Net income was $6.73B. Revenue was up 9.7% from 2024-12-31 to 2025-12-31. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
ANGO currently screens at market cap $378.5M. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Not investment advice. Open the ANGO and RTX stock pages for the full models.
Not investment advice.